Evotec cuts 50 jobs and seeks partners to reduce R&D risk
Germany’s Evotec has announced job cuts as part of a bid to significantly reduce its costs, while looking for partners for its R&D programmes.
Read MoreAuthor: Kevin Grogan
Amylin and Lilly to file Byetta LAR before the end of June
Amylin, Eli Lilly and Alkermes say they will soon file their once-weekly version of the diabetes blockbuster Byetta and have presented data on the standard drug which showed no increased risk of cardiovascular events.
Read MoreGPC losses narrow, excited about future with Agennix
Germany’s GPC Biotech, which is in the process of combining with the USA’s Agennix, has posted a narrowing of losses for 2008 though its revenues are sinking.
Read MoreRoche now holds 96.2% stake in Genentech, delisting soon
Roche says that its tender offer for stock in Genentech it did not already own has been completed, giving it control of over 96% of the shares in US biotechnology giant.
Read MoreGSK to buy a stake in Aspen or acquire Allergan?
It looks as though GlaxoSmithKline is on the verge of buying a significant stake in South Africa’s Aspen while rumours persist that the UK-based drugs giant is planning to acquire the USA’s Allergan.
Read More- FDA approves new high dose Spinraza regimen for SMA
- Viridian reports positive results from elegrobart phase 3 trial
- Cure Parkinson’s convenes expert panel to assess £2 million combination therapy funding call
- Kygevvi approved in Europe as first treatment for TK2d
- Tozorakimab shows significant benefit in two major COPD trials
